Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chubb
AstraZeneca
Colorcon
UBS
Express Scripts
Fish and Richardson
Johnson and Johnson
US Army
McKinsey

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,194,429

« Back to Dashboard

Summary for Patent: 6,194,429
Title: Alatrofloxacin parenteral compositions
Abstract:The present invention relates to alatrofloxacin mesylate substantially free of less polar impurities, to parenteral compositions of alatrofloxacin mesylate and to processes for purifying alatrofloxacin mesylate.
Inventor(s): Guinn; Robert Mark (Mystic, CT), Lambert; John Francis (North Stonington, CT), Guhan; Subramanian Sam (Niantic, CT), Walinsky; Stanley Walter (Mystic, CT)
Assignee: Pfizer Inc (New York, NY)
Application Number:09/403,886
Patent Claim Types:
see list of patent claims
Compound; Process; Use; Composition;

Drugs Protected by US Patent 6,194,429

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,194,429

PCT Information
PCT FiledJuly 23, 1998PCT Application Number:PCT/IB98/01122
PCT Publication Date:February 11, 1999PCT Publication Number: WO99/06430

International Patents Family Members for US Patent 6,194,429

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 1031 ➤ Sign Up
Argentina 015417 ➤ Sign Up
Austria 259827 ➤ Sign Up
Australia 734863 ➤ Sign Up
Australia 8236898 ➤ Sign Up
Bulgaria 104105 ➤ Sign Up
Brazil 9811580 ➤ Sign Up
Canada 2296466 ➤ Sign Up
China 1265671 ➤ Sign Up
Colombia 4970688 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Moodys
US Department of Justice
Fuji
Cantor Fitzgerald
Federal Trade Commission
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot